• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

13 个大 parkin 缺失/重复的断点作图揭示了一个exon4 缺失和一个exon7 重复作为主要突变。

Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.

机构信息

Department of Clinical Genetics, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Neurogenetics. 2011 Nov;12(4):263-71. doi: 10.1007/s10048-011-0302-9. Epub 2011 Oct 13.

DOI:10.1007/s10048-011-0302-9
PMID:21993715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3215878/
Abstract

Early-onset Parkinson's disease (EOPD) has been associated with recessive mutations in parkin (PARK2). About half of the mutations found in parkin are genomic rearrangements, i.e., large deletions or duplications. Although many different rearrangements have been found in parkin before, the exact breakpoints involving these rearrangements are rarely mapped. In the present study, the exact breakpoints of 13 different parkin deletions/duplications, detected in 13 patients out of a total screened sample of 116 EOPD patients using Multiple Ligation Probe Amplification (MLPA) analysis, were mapped using real time quantitative polymerase chain reaction (PCR), long-range PCR and sequence analysis. Deletion/duplication-specific PCR tests were developed as a rapid and low cost tool to confirm MLPA results and to test family members or patients with similar parkin deletions/duplications. Besides several different deletions, an exon 3 deletion, an exon 4 deletion and an exon 7 duplication were found in multiple families. Haplotype analysis in four families showed that a common haplotype of 1.2 Mb could be distinguished for the exon 7 duplication and a common haplotype of 6.3 Mb for the deletion of exon 4. These findings suggest common founder effects for distinct large rearrangements in parkin.

摘要

早发性帕金森病(EOPD)与 parkin(PARK2)的隐性突变有关。在 parkin 中发现的大约一半突变是基因组重排,即大片段缺失或重复。尽管以前已经在 parkin 中发现了许多不同的重排,但这些重排的确切断点很少被映射。在本研究中,使用实时定量聚合酶链反应(PCR)、长距离 PCR 和序列分析,对 13 例 EOPD 患者的 13 种不同 parkin 缺失/重复,通过多重连接探针扩增(MLPA)分析检测到,对其确切断点进行了映射。缺失/重复特异性 PCR 测试被开发为一种快速且低成本的工具,用于确认 MLPA 结果以及测试具有类似 parkin 缺失/重复的家族成员或患者。除了几种不同的缺失外,还在多个家族中发现了一个外显子 3 缺失、一个外显子 4 缺失和一个外显子 7 重复。四个家族的单倍型分析表明,外显子 7 重复可以区分出一个常见的 1.2Mb 单倍型,外显子 4 缺失可以区分出一个常见的 6.3Mb 单倍型。这些发现表明,parkin 中不同的大片段重排存在共同的起源效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/0ba6ca525c69/10048_2011_302_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/07981fe19da2/10048_2011_302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/e6fa1fc1652a/10048_2011_302_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/a141821e4a84/10048_2011_302_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/0ba6ca525c69/10048_2011_302_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/07981fe19da2/10048_2011_302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/e6fa1fc1652a/10048_2011_302_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/a141821e4a84/10048_2011_302_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8664/3215878/0ba6ca525c69/10048_2011_302_Fig4_HTML.jpg

相似文献

1
Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.13 个大 parkin 缺失/重复的断点作图揭示了一个exon4 缺失和一个exon7 重复作为主要突变。
Neurogenetics. 2011 Nov;12(4):263-71. doi: 10.1007/s10048-011-0302-9. Epub 2011 Oct 13.
2
Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.帕金森病基因(PARK2)外显子1 - 12剂量的有效定量实时聚合酶链反应分析。
BMC Med Genet. 2007 Feb 26;8:6. doi: 10.1186/1471-2350-8-6.
3
Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.利用多重连接依赖探针扩增技术分析中国早发性帕金森病患者的外显子剂量
Eur Neurol. 2019;81(5-6):246-253. doi: 10.1159/000503421. Epub 2019 Oct 16.
4
Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.一个有早发性帕金森病的汉族家庭携带 PARK2 基因的新型复合杂合突变。
Brain Behav. 2019 Sep;9(9):e01372. doi: 10.1002/brb3.1372. Epub 2019 Aug 6.
5
Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.确定两个帕金森病不同家系中Parkin基因第4外显子缺失的末端。
Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):120-3. doi: 10.1002/ajmg.b.30119.
6
Genomic instability in the PARK2 locus is associated with Parkinson's disease.PARK2基因座的基因组不稳定性与帕金森病相关。
J Appl Genet. 2015 Nov;56(4):451-461. doi: 10.1007/s13353-015-0282-9. Epub 2015 Apr 2.
7
Distribution, type, and origin of Parkin mutations: review and case studies.帕金森蛋白(Parkin)突变的分布、类型及起源:综述与病例研究
Mov Disord. 2004 Oct;19(10):1146-57. doi: 10.1002/mds.20234.
8
Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.巴西帕金森病患者的外显子剂量变化:SNCA、PARKIN、PINK1 和 DJ-1 基因分析。
Dis Markers. 2012;32(3):173-8. doi: 10.3233/DMA-2011-0873.
9
Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.中国散发性帕金森病患者中帕金基因的外显子剂量分析
Neurosci Lett. 2015 Sep 14;604:47-51. doi: 10.1016/j.neulet.2015.07.046. Epub 2015 Aug 1.
10
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.帕金基因和PINK1基因在约旦早发型和青少年帕金森病家族中的意义。
BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47.

引用本文的文献

1
Large-scale copy number variant analysis in genes linked to Parkinson´s disease.与帕金森病相关基因的大规模拷贝数变异分析。
NPJ Parkinsons Dis. 2025 Aug 1;11(1):225. doi: 10.1038/s41531-025-01076-y.
2
Genome-wide association study of copy number variations in Parkinson's disease.帕金森病拷贝数变异的全基因组关联研究。
medRxiv. 2024 Aug 22:2024.08.21.24311915. doi: 10.1101/2024.08.21.24311915.
3
Genetic landscape of Parkinson's disease and related diseases in Luxembourg.卢森堡帕金森病及相关疾病的遗传图谱

本文引用的文献

1
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.SNCA、PARK2、PINK1、PARK7 和 LRRK2 基因突变与帕金森病的遗传病因学:突变更新。
Hum Mutat. 2010 Jul;31(7):763-80. doi: 10.1002/humu.21277.
2
A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.一种使用锁核酸修饰寡核苷酸的实时聚合酶链反应测定法,用于快速、敏感、特异性定量 JAK2V617F 突变。
J Mol Diagn. 2010 Jul;12(4):512-9. doi: 10.2353/jmoldx.2010.090137. Epub 2010 Apr 29.
3
Front Aging Neurosci. 2023 Dec 20;15:1282174. doi: 10.3389/fnagi.2023.1282174. eCollection 2023.
4
Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies.从 4800 个外显子组中获得的拷贝数变异导致了约 7%的运动障碍、肌肉疾病和神经病变的遗传诊断。
Eur J Hum Genet. 2023 Jun;31(6):654-662. doi: 10.1038/s41431-023-01312-0. Epub 2023 Feb 13.
5
The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials.基因检测在匈牙利队列早发性帕金森氏症疾病临床实践与研究中的作用:基因咨询面临的挑战日益增加,临床试验分层的机会得到改善
Front Genet. 2019 Oct 31;10:1061. doi: 10.3389/fgene.2019.01061. eCollection 2019.
6
Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach.帕金森病中的拷贝数变异:通过系统生物学方法拼凑谜团。
Hum Genet. 2017 Jan;136(1):13-37. doi: 10.1007/s00439-016-1749-4. Epub 2016 Nov 28.
7
Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.GNE肌病中缺失的基因变异:包含5'非翻译区的重排热点和奠基者等位基因。
J Hum Genet. 2017 Feb;62(2):159-166. doi: 10.1038/jhg.2016.134. Epub 2016 Nov 10.
8
Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD.在一组 PD 患者中发现的 PARK2 大片段缺失的基因组机制。
Neurol Genet. 2016 May 3;2(3):e73. doi: 10.1212/NXG.0000000000000073. eCollection 2016 Jun.
9
Genomic instability in the PARK2 locus is associated with Parkinson's disease.PARK2基因座的基因组不稳定性与帕金森病相关。
J Appl Genet. 2015 Nov;56(4):451-461. doi: 10.1007/s13353-015-0282-9. Epub 2015 Apr 2.
10
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.PRKN 和 SNCA 基因突变与帕金森病的进展有关。
Curr Genomics. 2013 Dec;14(8):502-17. doi: 10.2174/1389202914666131210205839.
Analysis of exon dosage using MLPA in South African Parkinson's disease patients.
使用 MLPA 分析南非帕金森病患者的外显子剂量。
Neurogenetics. 2010 Jul;11(3):305-12. doi: 10.1007/s10048-009-0229-6. Epub 2009 Dec 15.
4
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.帕金森病相关基因 PARK2 的体细胞突变与神经胶质瘤和其他人类恶性肿瘤有关。
Nat Genet. 2010 Jan;42(1):77-82. doi: 10.1038/ng.491. Epub 2009 Nov 29.
5
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.荷兰早发性帕金森病患者的基因型和表型特征。
Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287.
6
Genetics of parkinsonism.帕金森症的遗传学
Parkinsonism Relat Disord. 2007;13 Suppl 3:S233-41. doi: 10.1016/S1353-8020(08)70008-7.
7
Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.用于同时检测帕金森病基因重排的多重连接依赖探针扩增检测法。
Mov Disord. 2007 Nov 15;22(15):2274-8. doi: 10.1002/mds.21532.
8
Rapid identification of disease-causing mutations using copy number analysis within linkage intervals.利用连锁区间内的拷贝数分析快速鉴定致病突变
Hum Mutat. 2007 Dec;28(12):1236-40. doi: 10.1002/humu.20592.
9
Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2).常染色体隐性遗传性帕金森病(PARK2)患者成纤维细胞中帕金基因复合杂合缺失的检测
Neurosci Lett. 2006 May 29;400(1-2):44-7. doi: 10.1016/j.neulet.2006.02.035. Epub 2006 Mar 6.
10
Common fragile sites, extremely large genes, neural development and cancer.常见脆性位点、超大基因、神经发育与癌症
Cancer Lett. 2006 Jan 28;232(1):48-57. doi: 10.1016/j.canlet.2005.06.049. Epub 2005 Oct 10.